Polar Distribution of MicroRNAs Discovered within Eukaryotic Cells
News Jun 11, 2015
A central question in developmental biology is how the original fertilized oocyte gives rise to a complex organism made up of hundreds of different cell types. The key mechanism is asymmetric cell division that produces daughter cells with uneven distribution of deterministic biomolecules leading to different fates.
Certain proteins and messenger RNAs (mRNAs) have previously been identified as cell fate determinants. In a study published in Scientific Reports from Nature Publishing Group the Institute of Biotechnology of the Czech Republic (IBT CAS), the TATAA Biocenter in Sweden, and the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants.
Using real-time polymerase chain reaction (qPCR) tomography that the groups developed previously and a new technique for sensitive profiling of microRNAs invented at the EMBL, the team sliced single oocytes from the frog Xenopus laevis across the animal-vegetal (top-down) axis and measured intracellular profiles of microRNAs within the individual cells. Two distinct distributions were found.
One, which is likely to form spontaneously, with the microRNAs centered on the nucleus, and one with the microRNAs predominant in the vegetal hemisphere. The 1st and 2nd divisions of the oocyte are along the animal-vegetal symmetry axis and are not affected by the microRNA gradient discovered, but the 3rd division cuts across producing two sets of four daughter cells that will be different.
“This is an important discovery towards our understanding of the complex mechanisms behind asymmetric cell division leading to differentiation and the formation of advanced organisms” says Dr Radek Sindelka, group leader at the IBT and one of the lead authors.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE